Cytokinetics Inc. buy Barclays PLC
Start price
28.01.26
/
50%
€53.50
Target price
28.01.27
€72.55
Performance (%)
0.00%
Price
26.02.26
€53.50
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC is currently unchanged from the start price. This prediction currently runs until 28.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -7.759% | - |
| iShares Core DAX® | -0.383% | |
| iShares Nasdaq 100 | -0.411% | |
| iShares Nikkei 225® | 1.838% | |
| iShares S&P 500 | -0.712% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $87.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.60
03.09.25
03.09.25
€61.04
03.09.26
03.09.26
28.61%
26.02.26
26.02.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
84.48%
26.02.26
26.02.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.60
24.04.25
24.04.25
€48.44
24.04.26
24.04.26
59.23%
26.02.26
26.02.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25